Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL *** > Treatment > Co: CA. V. Bexarotene Brand Cap.

---

Co: CA. V. Bexarotene Brand Cap.'s subsections
(*) USA Approval Date: 1999. 12.29
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2006. 10.31
Patent>USA Expiration: 2012. 11.25
TradeMark
TradeMark Web-Site

Co: CA. V. Bexarotene Brand Cap.'s products
This section has no products